Skip to main content
Medicine LibreTexts

6.7: Cardiac Glycosides

  • Page ID
    24281
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    Digoxin

    Digoxin is a cardiac glycoside medication that has been used for centuries to treat heart failure. It has three effects on heart muscle: positive inotropic action (increases contractility, stroke volume and, thus, cardiac output), negative chronotropic action (decreases heart rate), and negative dromotropic action (decrease conduction of cardiac cells).[1]

    Mechanism of Action

    Digoxin works by inhibiting the sodium and potassium pump, which results in an increase in intracellular sodium and an influx of calcium into cardiac cells, causing the cardiac muscle fibers to contract more efficiently and increase cardiac output.[2]

    Indications for Use

    This medication is used as second-line treatment for patients who have heart failure or atrial fibrillation. Due to the risk for digoxin toxicity, the clinical use of digoxin has decreased and alternative, safer medications are being used.

    Nursing Considerations Across the Lifespan

    Apical pulse should be taken for a full minute before administration of this medication. If the apical pulse is less than 60, the dose should be withheld and the prescribing provider notified.

    Serum digoxin levels should be monitored, with a normal therapeutic range from 0.8 to 2 ng/mL.

    Serum potassium levels should also be closely monitored for patients on digoxin because hypokalemia increases the effect of digoxin and can result in digoxin toxicity. Normal potassium level is 3.5 to 5.0 mEq/L, and a result less than 3.5 should be immediately reported to the provider.

    Nurses should closely monitor signs of digoxin toxicity. Geriatric patients have an increased risk for developing digoxin toxicity. Digibind is used to treat digoxin toxicity.

    Adverse/Side Effects

    Overdose or accumulation of digoxin causes digoxin toxicity. Signs and symptoms of digoxin toxicity are bradycardia (heart rate less than 60), nausea, vomiting, visual changes (halos), and arrhythmias. Cardiotoxicity is a serious adverse effect with ventricular dysrhythmias. Toxicity of this medication typically occurs at greater than 2 ng/mL, but some patients may have signs and symptoms at lower levels. Pediatric patients typically present with bradycardia or arrhythmias if toxicity is occuring.

    Decreased renal function, hypokalemia, hypercalcemia, and hypomagnesemia may increase risk for digoxin toxicity.

    Common side effects include GI symptoms, headache, weakness, dizziness, anxiety, depression, delirium, and hallucination.[3]

    Patient Teaching & Education

    The patient should be instructed to follow the prescribed dosing regimen and take medications at the same time each day. The patient should be cautious not to double up on medication doses. Additionally, the patient should consult the healthcare provider if two or more doses of medication are missed for follow-up instruction.

    Patients should receive education regarding pulse rate monitoring and report any pulse rate less than 60. If the patient experiences signs of digoxin toxicity, this should be reported to the provider immediately. The medication should be stored in its original container and care should be taken not to mix the medication with other medications.[4]

    Now let’s take a closer look at the medication grid for digoxin in Table 6.7a.[5]

    Table 6:7a Digoxin Medication Grid

    Class/Subclass

    Prototype-generic

    Administration Considerations

    Therapeutic Effects Adverse/Side Effects
    Cardiac glycosides digoxin Assess apical heart rate

    Assess serum digoxin and potassium levels

    Assess for signs and symptoms of digoxin toxicity

    Increased cardiac output Digoxin toxicity; early signs include nausea, vomiting, and diarrhea

    Bradycardia and arrhythmias

    Headache, weakness, dizziness, and mental changes such as anxiety or hallucinations

    Gynecomastia (with prolonged use)

    Critical Thinking Activities 6.7a
    Image of lightbulb in a circle

    1. Why should a nurse assess the apical pulse for 1 full minute before administering digoxin?
    2. How does a nurse evaluate if digoxin is effective?
    3. Why must the nurse monitor serum potassium levels as well as digoxin levels?
    4. A nurse enters a patient’s room and the patient complains “My vision seems strange and I feel nauseated.” What is the nurse’s next best action?

    Note: Answers to the Critical Thinking activities can be found in the “Answer Key” sections at the end of the book.

    Digibind

    Digibind is used to treat digoxin toxicity.

    Mechanism of Action

    Digibind binds to digoxin molecules, reducing free digoxin.

    Indications for Use

    This medication is the antidote for digoxin. Digibind will be administered when a patient is experiencing life-threatening digoxin toxicity.

    Nursing Considerations Across the Lifespan

    There are no contraindications when using digibind.

    Adverse/Side Effects

    The most common effects a patient may experience are to have worsening heart failure, worsening atrial fibrillation, and hypokalemia. [6]

    Patient Teaching & Education

    The patient should report any signs of worsening heart failure, atrial fibrillation, or hypokalemia immediately to the healthcare provider.[7]

    Now let’s take a closer look at the medication grid for digibind in Table 5.6b.[8]

    Table 5:6b Medication Grid for Digibind.
    Class/

    Subclass

    Prototype-

    generic

    Administration

    Considerations

    Therapeutic Effects Adverse/Side Effects
    Antidote digoxin immune fab (Digibind) Give when patients are experiencing life- threatening digoxin toxicity Reduce free digoxin Worsening heart failure

    Worsening atrial fibrillation

    Hypokalemia


    1. McCuistion, L., Vuljoin-DiMaggio, K., Winton, M, & Yeager, J. (2018). Pharmacology: A patient-centered nursing process approach. pp. 443-454. Elsevier. ↵
    2. McCuistion, L., Vuljoin-DiMaggio, K., Winton, M, & Yeager, J. (2018). Pharmacology: A patient-centered nursing process approach. pp. 443-454. Elsevier. ↵
    3. This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain. ↵
    4. uCentral from Unbound Medicine. https://www.unboundmedicine.com/ucentral
    5. This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain. ↵
    6. This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain. ↵
    7. uCentral from Unbound Medicine. https://www.unboundmedicine.com/ucentral
    8. This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain. ↵

    This page titled 6.7: Cardiac Glycosides is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by Ernstmeyer & Christman (Eds.) (OpenRN) via source content that was edited to the style and standards of the LibreTexts platform; a detailed edit history is available upon request.